Summary.
α-Synuclein, a synaptic protein of unknown function, is a major component of Lewy bodies and may play a role in the pathophysiological process of Parkinson’s disease (PD). In this study, we measured the plasma α-synuclein levels in 105 patients with PD, 38 patients with multiple system atrophy (MSA), and 51 age-matched controls. The α-synuclein level was significantly elevated in patients with PD (79.9 ± 4.0 pg/ml, p < 0.001) and in those with MSA (78.1 ± 3.5 pg/ml, p = 0.019) compared with the level in controls (76.1 ± 3.9 pg/ml). The α-synuclein level was higher in patients with PD than in those with MSA (79.9 ± 4.0 vs 78.1 ± 3.5, p = 0.016). Our study demonstrated that the α-synuclein level in plasma is elevated in patients with PD and MSA.
Similar content being viewed by others
References
R Borghi R Marchese A Negro L Marinelli G Forloni D Zaccheo G Abbruzzese M Tabaton (2000) ArticleTitleFull length alpha-synuclein is present in cerebrospinal fluid from Parkinson’s disease and normal subjects Neurosci Lett 287 65–67 Occurrence Handle10841992 Occurrence Handle1:CAS:528:DC%2BD3cXjslOqs7k%3D Occurrence Handle10.1016/S0304-3940(00)01153-8
MC Chartier-Harlin J Kachergus C Roumier V Mouroux X Douay S Lincoln C Levecque L Larvor J Andrieux M Hulihan N Waucquier L Defebvre P Amouyel M Farrer A Destee (2004) ArticleTitleAlpha-synuclein locus duplication as a cause of familial Parkinson’s disease Lancet 364 1167–1169 Occurrence Handle15451224 Occurrence Handle1:CAS:528:DC%2BD2cXnvVOiu7Y%3D Occurrence Handle10.1016/S0140-6736(04)17103-1
RB DeMattos KR Bales DJ Cummins SM Paul DM Holtzman (2002) ArticleTitleBrain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer’s disease Science 295 2264–2267 Occurrence Handle11910111 Occurrence Handle1:CAS:528:DC%2BD38XitlGkt7g%3D Occurrence Handle10.1126/science.1067568
KK Dev K Hofele S Barbieri VL Buchman H van der Putten (2003) ArticleTitlePart II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease Neuropharmacology 45 14–44 Occurrence Handle12814657 Occurrence Handle1:CAS:528:DC%2BD3sXks1alsrw%3D Occurrence Handle10.1016/S0028-3908(03)00140-0
OM El-Agnaf SA Salem KE Paleologou LJ Cooper NJ Fullwood MJ Gibson MD Curran JA Court DM Mann S Ikeda MR Cookson J Hardy D Allsop (2003) ArticleTitleAlpha-synuclein implicated in Parkinson’s disease is present in extracellular biological fluids, including human plasma FASEB J 17 1945–1947 Occurrence Handle14519670 Occurrence Handle1:CAS:528:DC%2BD3sXot1Kit7Y%3D
WP Gai JH Power PC Blumbergs WW Blessing (1998) ArticleTitleMultiple-system atrophy: a new α-synuclein disease? Lancet 352 547–548 Occurrence Handle9716068 Occurrence Handle1:STN:280:DyaK1cznvF2htw%3D%3D Occurrence Handle10.1016/S0140-6736(05)79256-4
J Hardy MR Cookson A Singleton (2003) ArticleTitleGenes and parkinsonism Lancet Neurol 2 221–228 Occurrence Handle12849210 Occurrence Handle1:CAS:528:DC%2BD3sXkvVKqt7w%3D Occurrence Handle10.1016/S1474-4422(03)00350-8
MM Hoehn MD Yahr (1967) ArticleTitleParkinsonism: onset, progression and mortality Neurology 17 427–442 Occurrence Handle6067254 Occurrence Handle1:STN:280:CCiC3sbgtlQ%3D Occurrence Handle10.1159/000137111
AJ Hughes SE Daniel L Kilford AJ Lees (1992) ArticleTitleAccuracy of clinical diagnosis of idiopathic Parkinsonism – a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 55 181–184 Occurrence Handle1564476 Occurrence Handle1:STN:280:By2B38nnsFQ%3D Occurrence Handle10.1136/jnnp.55.3.181
P Ibanez AM Bonnet B Debarges E Lohmann F Tison P Pollak Y Agid A Durr A Brice (2004) ArticleTitleCausal relation between alpha-synuclein gene duplication and familial Parkinson’s disease Lancet 364 1169–1171 Occurrence Handle15451225 Occurrence Handle1:CAS:528:DC%2BD2cXnvVOiu7c%3D Occurrence Handle10.1016/S0140-6736(04)17104-3
KA Jellinger (2003) ArticleTitleNeuropathological spectrum of synucleinopathies Mov Disord 18 S2–S12 Occurrence Handle14502650 Occurrence Handle10.1002/mds.10557
R Kruger W Kuhn T Muller D Woitalla M Graeber S Kosel H Przuntek JT Epplen L Schols O Riess (1998) ArticleTitleAla30Pro mutation in the gene encoding alpha-synuclein in Parkinson’s disease Nat Genet 18 106–108 Occurrence Handle9462735 Occurrence Handle1:CAS:528:DyaK1cXosFCntA%3D%3D Occurrence Handle10.1038/ng0298-106
DW Miller SM Hague J Clarimon M Baptista K Gwinn-Hardy MR Cookson AB Singleton (2004) ArticleTitleAlpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication Neurology 62 1835–1838 Occurrence Handle15159488 Occurrence Handle1:CAS:528:DC%2BD2cXjs1yltbs%3D
R Motter C Vigo-Pelfrey D Kholodenko R Barbour K Johnson-Wood D Galasko L Chang B Miller C Clark R Green D Olson P Southwick R Wolfert B Munroe I Lieberburg P Seubert D Schenk (1995) ArticleTitleReduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer’s disease Ann Neurol 38 643–648 Occurrence Handle7574461 Occurrence Handle1:STN:280:BymD3c7it1U%3D Occurrence Handle10.1002/ana.410380413
MH Polymeropoulos C Lavedan E Leroy SE Ide A Dehejia A Dutra B Pike H Root J Rubenstein R Boyer ES Stenroos S Chandrasekharappa A Athanassiadou T Papapetropoulos WG Johnson AM Lazzarini RC Duvoisin G Di Iorio LI Golbe RL Nussbaum (1997) ArticleTitleMutation in the alpha-synuclein gene identified in families with Parkinson’s disease Science 276 2045–2047 Occurrence Handle9197268 Occurrence Handle1:CAS:528:DyaK2sXkt1altr4%3D Occurrence Handle10.1126/science.276.5321.2045
Quinn NP (1989) Multiple system atrophy-the nature of the beast. J Neurol Neurosurg Psychiatry [Suppl]: 78–89
MG Spillantini ML Schmidt VM Lee JQ Trojanowski R Jakes M Goedert (1997) ArticleTitleAlpha-synuclein in Lewy bodies Nature 388 839–840 Occurrence Handle9278044 Occurrence Handle1:CAS:528:DyaK2sXlslWru7o%3D Occurrence Handle10.1038/42166
EK Tan VR Chandran S Fook-Chong H Shen K Yew ML Teoh Y Yuen Y Zhao (2005) ArticleTitleAlpha-synuclein mRNA expression in sporadic Parkinson’s disease Mov Disord 20 620–623 Occurrence Handle15719423 Occurrence Handle10.1002/mds.20391
J Zarranz J Alegre J Gomez-Esteban E Lezcano R Ros I Ampuero L Vidal J Hoenicka O Rodriguez B Atares V Llorens E Gomez Tortosa T del Ser DG Munoz JG de Yebenes (2004) ArticleTitleThe new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia Ann Neurol 55 164–173 Occurrence Handle14755719 Occurrence Handle1:CAS:528:DC%2BD2cXhs1Sgtb0%3D Occurrence Handle10.1002/ana.10795
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lee, P., Lee, G., Park, H. et al. The plasma alpha-synuclein levels in patients with Parkinson’s disease and multiple system atrophy. J Neural Transm 113, 1435–1439 (2006). https://doi.org/10.1007/s00702-005-0427-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-005-0427-9